SYNTAX血运重建指数对BP-DES置入冠心病患者长期预后的评估价值
SRI=100%组患者源性复合终点(PoCE)发生率显著低于其他两组,ROC曲线确定SRI=65%为预测全因死亡的最佳界值,SRI<65%是全因死亡和PoCE的独立危险因素。
要点
- SRI=100%组48个月PoCE发生率显著低于50%≤SRI<100%组和SRI<50%组。
- SRI<65%是48个月全因死亡(HR=2.06)和PoCE(HR=1.34)的独立危险因素。
- SRI≥65%可能是BP-DES置入患者合理的不完全血运重建界值。
核心结论
- SRI对置入BP-DES的冠心病患者长期预后具有较好区分度。
- SRI<65%是48个月PoCE和全因死亡的独立危险因素。
- SRI≥65%可能是合理的不完全血运重建界值。
研究设计与样本
- 数据来源于I-LOVE-IT 2前瞻性、多中心、随机对照、对评价者设盲的非劣效性研究。
- 主要终点为48个月患者源性复合终点(PoCE),包含全因死亡、心肌梗死、卒中和/或任何血运重建。
主要发现
- 48个月PoCE发生率:SRI=100%组17.34%(167/963),50%≤SRI<100%组22.20%(117/527),SRI<50%组24.78%(84/339),SRI=100%组均显著更低(P<0.05)。
- 50%≤SRI<100%组较SRI=100%组全部心肌梗死发生率更高(7.78% vs. 4.26%,P<0.05),靶血管心肌梗死发生率也更高(6.45% vs. 4.26%,P<0.05)。
- SRI<50%组较SRI=100%组全因死亡率更高(5.90% vs. 3.12%,P<0.05),任何血运重建发生率也更高(14.16% vs. 3.12%,P<0.05)。
关键数值与推荐
- ROC曲线确定SRI=65%为预测48个月全因死亡的最佳界值(AUC=0.58,敏感度0.47,特异度0.70)。
- SRI<65%预测48个月全因死亡的HR=2.06(95%CI 1.25-3.38),预测PoCE的HR=1.34(95%CI 1.09-1.66)。
临床怎么用
- 对置入BP-DES的冠心病患者可计算SRI进行危险分层。
- SRI<65%提示长期全因死亡和PoCE风险增高,需加强随访管理。
- SRI≥65%可作为不完全血运重建的合理参考界值。
局限性
- ROC曲线下面积为0.58,敏感度0.47,预测区分度有限。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Objective: To explore the value of SYNTAX revascularization index (SRI) on evaluating the long-term prognosis of coronary artery disease (CAD) patients implanted with biodegradable polymer drug-eluting stents (BP-DES) and define the best threshold of SRI for predicting all-cause mortality in these patients. Methods: Data used in this study derived from the I-LOVE-IT 2 trial (evaluate safety and effectiveness of the Tivoli DES and the Firebird DES for treatment of coronary). I-LOVE-IT 2 trial was a prospective, multicenter, randomized, assessor-blinded, non-inferiority study. A total of 1 829 patients implanted with BP-DES were divided into 3 groups, namely SRI=100% group (n=963), 50%≤SRI<100% group (n=527) and SRI<50% group (n=339). The primary endpoint was 48-month patient-oriented composite endpoint (PoCE), a composite of all-cause mortality, myocardial infarction(MI), stroke, and/or any revascularization. The secondary endpoints were components of PoCE and definite/probable stent thrombosis at 48 months. The receiver operating characteristic curve was used to investigate the best cut-off point of SRI for 48-month all-cause mortality. The Cox regression analysis was used to identify independent predictors of the all-cause death and PoCE at 48 months. Results: Incidence of PoCE at 48 months was significantly lower in SRI=100% group than patients with 50%≤SRI<100%(17.34% (167/963) vs. 22.20% (117/527), P<0.05) and SRI<50% (17.34% (167/963) vs. 24.78% (84/339), P<0.05). Comparing with SRI=100% group, the patients with 50%≤SRI<100% suffered higher rates of all MI (7.78% (41/527) vs. 4.26% (41/963), P<0.05) and target vessel MI (6.45% (34/527) vs. 4.26% (41/963), P<0.05); patients with SRI<50% had higher rates of all-cause mortality (5.90% (20/339) vs. 3.12% (30/963), P<0.05) and any revascularization (14.16% (48/339) vs. 3.12% (30/963), P<0.05). The receiver operating characteristic curve analysis showed that the SRI=65% was the best cut-off point to predict the all-cause mortality at 48 months (area under the curve was 0.58, sensitive was 0.47, specificity was 0.70). Meanwhile, SRI<65% was an independent predictor of 48-month all-cause mortality (HR=2.06, 95%CI 1.25-3.38) and PoCE (HR=1.34, 95%CI 1.09-1.66). Conclusions: SRI serves as a good index for predicting long-term prognosis and SRI<65% is an independent predictor of 48-month PoCE and all-cause mortality for CAD patients with BP-DES implantation. Meanwhile, SRI≥65% might be a reasonable threshold of incomplete revascularization. 目的: 探究基于SYNTAX血运重建指数(SRI)进行危险分层、置入生物可降解涂层药物洗脱支架(BP-DES)的冠心病患者的长期临床预后,并探究SRI预测该类患者全因死亡的最佳界值。 方法: 研究对象来自I-LOVE-IT 2研究,I-LOVE-IT 2研究是一项前瞻性、多中心、随机对照、对评价者设盲的非劣效性研究。本研究选取I-LOVE-IT 2研究中置入BP-DES的冠心病患者1 829例,计算纳入患者的SRI值,依据SRI水平将患者分为3组:SRI=100%组(963例)、50%≤SRI<100%组(527例)和SRI<50%组(339例)。置入支架后对患者进行随访,主要终点为48个月患者源性复合终点(PoCE),即包含全因死亡、心肌梗死、缺血性卒中和/或任何血运重建的复合终点;次要终点为48个月PoCE的各组成成分,以及肯定或可能的支架内血栓。使用受试者工作特征(ROC)曲线确定SRI预测48个月全因死亡的最佳界值,并采用多因素Cox回归模型验证该界值是否为48个月全因死亡和PoCE事件的独立危险因素。 结果: SRI=100%组患者的PoCE事件发生率低于50%≤SRI<100%组[17.34%(167/963)比22.20%(117/527),P<0.05]和SRI<50%组[17.34%(167/963)比24.78%(84/339),P<0.05]。与SRI=100%组比较,50%≤SRI<100%组患者全部的心肌梗死和靶血管心肌梗死事件发生率较高[分别为7.78%(41/527)比4.26%(41/963),P<0.05;6.45%(34/527)比4.26%(41/963),P<0.05];SRI<50%组患者的全因死亡和任何的血运重建发生率较高[分别为5.90%(20/339)比3.12%(30/963),P<0.05;14.16%(48/339)比3.12%(30/963),P<0.05]。ROC曲线显示预测48个月全因死亡的SRI的最佳界值为65%(ROC曲线下面积为0.58,敏感度0.47,特异度0.70)。多因素Cox回归分析结果显示SRI<65%是48个月全因死亡(HR=2.06,95%CI 1.25~3.38)和PoCE事件(HR=1.34,95%CI 1.09~1.66)的独立危险因素。 结论: 在预测置入BP-DES的冠心病患者长期的临床预后上,SRI具有较好的区分度,SRI<65%是48个月PoCE和全因死亡的独立危险因素。对于置入BP-DES的冠心病患者,SRI≥65%可能是一个合理的不完全血运重建的界值。.
引用
- Qiu MH, Bian LY, Fang CA, et al. [Value of SYNTAX revascularization index on evaluating the long-term prognosis of coronary artery disease patients with biodegradable polymer drug-eluting stents implantation]. Zhonghua Xin Xue Guan Bing Za Zhi. 2019. PMID: 31648461. doi:10.3760/cma.j.issn.0253-3758.2019.10.005
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。